Insmed Inc (INSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Cash Flows From Operating Activities | |||||
Net Income | -749,567 | -481,534 | -434,654 | -294,090 | -254,337 |
Depreciation Amortization | 20,611 | 16,282 | 46,299 | 35,606 | 29,923 |
Accounts receivable | -11,963 | -6,423 | -8,118 | 2,670 | -13,717 |
Accounts payable and accrued liabilities | 15,155 | 50,011 | -7,575 | 29,825 | -4,966 |
Other Working Capital | -39,218 | 6,575 | -58,580 | -2,954 | -62,969 |
Other Operating Activity | 228,735 | 14,650 | 99,326 | 9,595 | 55,417 |
Operating Cash Flow | $-536,247 | $-400,439 | $-363,302 | $-219,348 | $-250,649 |
Cash Flows From Investing Activities | |||||
PPE Investments | -13,288 | -9,878 | -7,289 | -6,240 | -42,268 |
Net Acquisitions | N/A | N/A | -6,704 | N/A | N/A |
Purchase Of Investment | -588,733 | -99,706 | -50,292 | N/A | N/A |
Sale Of Investment | 375,000 | 75,000 | 0 | N/A | N/A |
Purchase Sale Intangibles | N/A | N/A | N/A | -582 | N/A |
Other Investing Activity | 3,417 | 0 | 0 | -582 | 0 |
Investing Cash Flow | $-223,604 | $-34,584 | $-64,285 | $-6,822 | $-42,268 |
Cash Flows From Financing Activities | |||||
Debt Issued | 0 | 350,000 | 562,422 | N/A | N/A |
Debt Repayment | N/A | N/A | -225,000 | N/A | N/A |
Common Stock Issued | 170,874 | 311,657 | 291,923 | 271,939 | 280,775 |
Other Financing Activity | -2,435 | 131,616 | -16,799 | -936 | 4,503 |
Financing Cash Flow | $168,439 | $793,273 | $612,546 | $271,003 | $285,278 |
Exchange Rate Effect | -250 | -996 | -933 | 494 | -4 |
Beginning Cash Position | 1,074,036 | 716,782 | 532,756 | 487,429 | 495,072 |
End Cash Position | 482,374 | 1,074,036 | 716,782 | 532,756 | 487,429 |
Net Cash Flow | $-591,662 | $357,254 | $184,026 | $45,327 | $-7,643 |
Free Cash Flow | |||||
Operating Cash Flow | -536,247 | -400,439 | -363,302 | -219,348 | -250,649 |
Capital Expenditure | -13,288 | -9,878 | -7,289 | -6,240 | -42,268 |
Free Cash Flow | -549,535 | -410,317 | -370,591 | -225,588 | -292,917 |